Presented for research literature review only Iizuka T et al
Can diet help with mast cell activation syndrome

Ingredients: Water, Dipropylene Glycol, Glycerin, Butylene Glycol, Niacinamide, 1,2-Hexanediol, Polyglyceryl-10 Laurate, Polyglyceryl-4 Laurate, Betaine, Allantoin, Carbomer, Trehalose, Arginine, Caprylyl/Capryl Glucoside, Glutathione, Dipotassium Glycyrrhizate, Ethylhexylglycerin, Xanthan Gum, Fragrance, Glyceryl Acrylate/Acrylic Acid Copolymer, Disodium EDTA, Sodium Hyaluronate, Gluconolactone, Alcohol, Malva Sylvestris (Mallow) Extract, Melissa Officinalis Leaf Extract, Alchemilla Vulgaris Extract, Achillea Millefolium Extract, Veronica Officinalis Extract, Mentha Piperita (Peppermint) Leaf Extract, Hydrogenated Lecithin, Primula Veris Extract, Polyglyceryl-10 Stearate, Panthenol, Lycopodium Clavatum Extract, Sodium Ascorbyl Phosphate, Equisetum Arvense Extract, Sodium Hydroxide, Copper Tripeptide-1, Biotin, Acetyl Hexapeptide-8, Palmitoyl Pentapeptide-4, Folic Acid, Pyridoxine, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, Cyanocobalamin, Tocopherol, Linoleic Acid, Riboflavin, Beta-Carotene, Thiamine HCl

Within the findings were several considerations for patients and payers: High costs for GLP-1 medications ranked as respondents top concern (followed by lack of control over who is prescribed the medications) 93% covered GLP-1s for management of diabetes in the previous plan year
Some patients have explored purchasing from international sources, yet this carries risks around product consistency, regulatory oversight, and customs enforcement